CD24 has been investigated for use in molecular targeted therapy, highlighting the potent anti-tumor effect of CD24 blockade and the potential to unravel the blockade of the immune system, suggesting the potential of its use beyond FIGS [16,90]. Here, CD24 is linked to neoplasm.